{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "1810733",
  "DateCompleted": {
    "Year": "1992",
    "Month": "06",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "08",
    "Day": "28"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0934-9723",
      "JournalIssue": {
        "Volume": "10",
        "Issue": "9",
        "PubDate": {
          "Year": "1991",
          "Month": "Sep"
        }
      },
      "Title": "European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology",
      "ISOAbbreviation": "Eur J Clin Microbiol Infect Dis"
    },
    "ArticleTitle": "Severe Rhodococcus equi pneumonia: case report and literature review.",
    "Pagination": {
      "StartPage": "762",
      "EndPage": "768",
      "MedlinePgn": "762-8"
    },
    "Abstract": {
      "AbstractText": [
        "Rhodococcus equi is an aerobic, gram-positive, non-motile pleomorphic bacillus infecting immunocompromised patients. Forty-nine cases of Rhodococcus equi infection have been reported, mainly in patients infected with the human immunodeficiency virus (HIV). A case in which Rhodococcus equi caused severe pulmonary infection, the most common presentation, is described. Clinically, patients have symptoms of pneumonia with hemoptysis as a prominent feature. X-ray will often show a cavitating upper-lobe infiltrate, resembling infection with mycobacteria. Rhodococcus equi is easily cultured from blood or sputum on standard media, but is frequently regarded as a contaminant. Mortality from Rhodococcus equi pneumonia is high (25%) and early surgical intervention has been recommended. Based on this review, the benefit of surgery seems dubious, whereas good results have been obtained using long-term antibiotic treatment with erythromycin plus rifampicin, or vancomycin in combination with either of these antibiotics."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Denmark."
          }
        ],
        "LastName": "Vestbo",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lundgren",
        "ForeName": "J D",
        "Initials": "JD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gaub",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "R\u00f8der",
        "ForeName": "B",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gutschik",
        "ForeName": "E",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Eur J Clin Microbiol Infect Dis",
    "NlmUniqueID": "8804297",
    "ISSNLinking": "0934-9723"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "63937KV33D",
      "NameOfSubstance": "Erythromycin"
    },
    {
      "RegistryNumber": "6Q205EH1VU",
      "NameOfSubstance": "Vancomycin"
    },
    {
      "RegistryNumber": "VJT6J7R4TR",
      "NameOfSubstance": "Rifampin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Acquired Immunodeficiency Syndrome"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Actinomycetales Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Drug Therapy, Combination"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Erythromycin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunocompromised Host"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Pneumonia"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Rhodococcus equi"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Rifampin"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Vancomycin"
    }
  ],
  "NumberOfReferences": "35"
}